SCHEDULE: FMR LLC Reports 11% Stake in Viatris Inc.
Beneficial Ownership Filing (Schedule 13G Amendment)
FMR LLC and Abigail P. Johnson have updated their Schedule 13G filing to reflect beneficial ownership of 11.0% of Viatris Inc.'s common stock as of August 31, 2026.
Summary
- FMR LLC and Abigail P. Johnson have filed an amendment to their Schedule 13G, reporting beneficial ownership of 126,764,446.45 shares of Viatris Inc. common stock.
- This represents 11.0% of the class of securities outstanding as of August 31, 2026.
- The filing indicates that FMR LLC has sole voting power and sole dispositive power over these shares.
- Abigail P. Johnson, as Director, Chairman, and CEO of FMR LLC, is also noted as having shared voting power and shared dispositive power through her ownership and a shareholders' voting agreement.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this filing as neutral, as it primarily reports a change in beneficial ownership percentage without disclosing new strategic or financial performance information.
Positives
- FMR LLC and its affiliates maintain a significant ownership stake (11.0%) in Viatris Inc., indicating continued investor confidence.
- The filing clearly outlines the beneficial ownership and voting/dispositive powers held by FMR LLC and Abigail P. Johnson.
Negatives
- The filing does not provide any new financial performance data or strategic updates for Viatris Inc.
- The information is a routine update on beneficial ownership, not indicative of new investment theses or performance changes.
Risks
- The filing does not explicitly mention any new risks or changes to existing risk factors for Viatris Inc.
Future Outlook
The filing does not contain any forward-looking statements or guidance regarding Viatris Inc.'s future performance.
Management Comments
- FMR LLC and Abigail P. Johnson certify that the securities were acquired and are held in the ordinary course of business and were not acquired or held for the purpose of or with the effect of changing or influencing the control of the issuer.
Industry Context
StockSavvy.ai notes that this filing is a standard Schedule 13G amendment, typically filed by institutional investors when their beneficial ownership of a public company's stock crosses certain thresholds. It reflects ongoing investment activity within the pharmaceutical and healthcare sectors.
Stakeholder Impact
- Shareholders: The filing confirms a significant institutional investor's stake, which can influence market perception and trading activity.
- Management: The filing provides transparency on ownership, which is a standard disclosure for corporate governance.
Next Steps
- FMR LLC and Abigail P. Johnson will continue to report any material changes in their beneficial ownership of Viatris Inc. common stock as required by SEC regulations.
Key Dates
| Date | Description |
|---|---|
| 2023-01-03 | Effective date of Power of Attorney for FMR LLC. |
| 2023-01-10 | Date of prior Schedule 13G filing by FMR LLC. |
| 2023-01-26 | Effective date of Power of Attorney for Abigail P. Johnson. |
| 2023-01-31 | Date of prior Schedule 13G filing by FMR LLC. |
| 2026-08-31 | Date of Event Which Requires Filing of this Statement (Reporting period end date). |
| 2026-09-04 | Date of joint filing agreement and signature date. |
Keywords
Viatris Inc., FMR LLC, Abigail P. Johnson, Schedule 13G, Beneficial Ownership, Common Stock, Investment Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.